About ZISKA Pharmaceutiacals
ZISKA Pharmaceutiacals is a Healthcare company based in Dhaka (Bangladesh) founded in 1989. It manufactures pharmaceutical products, innovates medicines, and operates in Bangladesh with global reach. It operates on a B2B model. Its website ziskapharma.com draws about 14 thousand monthly visits. ZISKA Pharmaceutiacals offers products and services including Dementa, Dexilend, Solupred, Upanib, and Aparkin. Its focus areas include Pharmaceuticals, Drug Manufacturing, Innovative Medicines and Drug Distribution. Its legal entity is Ziska Pharmaceuticals Ltd. Its competitors include Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences and 5 more; 5 of its 10 listed competitors have raised funding.
Company details
Ziska Pharmaceuticals Ltd. is a leading pharmaceutical company based in Bangladesh, operating for over 35 years. It manufactures and distributes a range of products including general, oncology, and hormonal medicines through research and development efforts. The company maintains facilities in Dhaka and Gazipur, focusing on quality and innovation to serve patients and healthcare providers worldwide. It emphasizes transparency and global operations to ensure effective medicine supply.
- Headquarters Dhaka, Bangladesh
- SectorsHealthcare
- Website category Health · Pharmacy
- Email••••••••
- Phone•••• ••••
- Website ziskapharma.com
- Social LinkedIn X Facebook
- Legal Name Ziska Pharmaceuticals Ltd.
Products & Services of ZISKA Pharmaceutiacals
ZISKA Pharmaceutiacals offers a comprehensive portfolio of products and services, including Dementa, Dexilend, Solupred, Upanib, and Aparkin.
Medication for treating dementia and related conditions.
Drug for specific therapeutic applications.
Steroid medication for inflammation control.
Oncology drug for cancer treatment.
Medication for neurological disorders.
Cardiovascular drug for heart conditions.
Respiratory medication for breathing issues.
Antibiotic for bacterial infections.
Antifungal treatment for infections.
Diabetes management medication.
Competitors of ZISKA Pharmaceutiacals
ZISKA Pharmaceutiacals has 10 listed competitors in our database, 5 of them funded. They include Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| zambon.com | 1906 | Bresso, Italy | – | – | APIs and finished drugs are developed and manufactured in pharmaceuticals. | |
| aenova-group.com | 2008 | Starnberg, Germany | – | – | CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | |
| leukocare.com | 2003 | Munich, Germany | $17.5M | 70 | Proprietary stabilizing solutions for biologics formulations are developed. |
Detailed competitors of ZISKA Pharmaceutiacals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ZISKA Pharmaceutiacals
The website of ZISKA Pharmaceutiacals (ziskapharma.com) receives about 13.8K visits a month and ranks #3,660,993 among all websites worldwide, #4,048 in Pharmacy.
- Monthly visits13.8K
▲ 187.5% vs previous month
- Unique visitors2.7K
per month
- Global rank#3,660,993
among all websites
- Category rank#4,048
Health · Pharmacy
- Bounce rate42%
- Pages per visit1.9
- Average visit23 sec
- DevicesDesktop 25% · Mobile 75%
Websites whose visitors overlap most with ZISKA Pharmaceutiacals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| beximcopharma.com | 94% | 12.7K | #2,141,679 | View details |
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as ZISKA Pharmaceutiacals (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ZISKA Pharmaceutiacals
ZISKA Pharmaceutiacals was founded in 1989.
ZISKA Pharmaceutiacals is headquartered in Dhaka, Bangladesh.
Ziska Pharmaceuticals Ltd. is a leading pharmaceutical company based in Bangladesh, operating for over 35 years. It manufactures and distributes a range of products including general, oncology, and hormonal medicines through research and development efforts. The company maintains facilities in Dhaka and Gazipur, focusing on quality and innovation to serve patients and healthcare providers worldwide. It emphasizes transparency and global operations to ensure effective medicine supply.
ZISKA Pharmaceutiacals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
ZISKA Pharmaceutiacals offers Dementa, Dexilend, Solupred, Upanib, and 6 more products and services.
ZISKA Pharmaceutiacals operates through Ziska Pharmaceuticals Ltd..